TY - JOUR AU - Li, Zhengtu AU - Li, Runfeng AU - Li, Jing AU - Xie, Hui AU - Hao, Yanbing AU - Du, Qiuling AU - Chen, Tingting AU - Li, Yimin AU - Chen, Rongchang AU - Yang, Zifeng AU - Zhong, Nanshan PY - 2016 DA - 2016/07/08 TI - Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment JO - BMC Infectious Diseases SP - 325 VL - 16 IS - 1 AB - China-made Peramivir, an anti-influenza neuraminidase inhibitor drug, is manufactured and widely used in China. Although effective if initiated within 48 h of the onset of symptoms, yet we observed that this drug shows an inconclusive efficacy if treatment is delayed in clinical. Thus we evaluated the efficacy of delayed treatment of China-made Peramivir in a mouse model. SN - 1471-2334 UR - https://doi.org/10.1186/s12879-016-1589-9 DO - 10.1186/s12879-016-1589-9 ID - Li2016 ER -